Fluidnatek

Bioinicia Fluidnatek

Bioinicia Fluidnatek is the electrospinning technology division of the Bioinicia Group, specialising in advanced nanofibre manufacturing solutions for the medical device, pharmaceutical and life sciences sectors.

Founded in 2012 as a spin-off from the Spanish National Research Council (CSIC), one of Europe's leading public research organisations, Bioinicia combines scientific expertise with industrial manufacturing experience to support the development of next-generation medical technologies.

The company focuses on the development and production of nanostructured materials using electrospinning and electrospraying technologies. Its platforms enable the creation of highly functional materials with applications ranging from wound care and drug delivery to tissue engineering, filtration and advanced medical device components.

Over the past decade, Bioinicia has established itself as a recognised leader in electrospinning technology, offering both needle-based and needle-free solutions to meet the evolving needs of research organisations, start-ups and global medical device manufacturers. Through close collaboration with industry partners, the company has gained extensive experience in translating laboratory-scale innovations into commercially viable manufacturing processes.

Beyond equipment development, Bioinicia supports organisations throughout the product development journey, from concept validation and process optimisation to scale-up and industrial production. This end-to-end expertise provides medical device OEMs with access to the knowledge, infrastructure and manufacturing insight required to accelerate the introduction of innovative products to market.

With a strong foundation in materials science, process engineering and regulatory-driven development, Bioinicia continues to help advance the use of electrospun and electrosprayed materials across a growing range of medical and healthcare applications.